New drug could soothe cat allergy eyes

NCT ID NCT06602726

Completed Symptom relief Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two experimental drugs, REGN1908 and REGN1909, mixed together to reduce eye allergy signs and symptoms in people with cat allergies. The goal was to see how safe and effective the drug is compared to a placebo. The study included 64 participants with a history of moderate to severe cat allergy. The main focus was on reducing eye itching and redness after exposure to cat allergens.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic conjunctivitis Conjunctivitis, Allergic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLERGIC CONJUNCTIVITIS

Contacts and locations

Show contact details

Locations

Andover Eye Associates

Andover, Massachusetts, 01810, United States
Clinique de Specialisee en Allergie de la Capitale

Québec, G1V 4W2, Canada
Kingston Health Sciences Centre

Kingston, Ontario, K7L 2V7, Canada
Red Maple Trials Inc.

Ottawa, Ontario, K1H 1E4, Canada